Stem-cell repair of spinal cords
Expect an exciting year in spinal cord repair. The Geron Corporation, based in America, is seeking approval for the first clinical trial using embryonic stem cells to repair human spinal cords, which would be conducted next year. By injecting the cells, which have the ability to turn into any cell of the body, they hope to replace damaged neurons.
Add to this work at University College London — where scientists believe that a cell from your nose, an olfactory ensheathing cell, can make the cells in the spinal cord regrow. In an area that can sometimes give false hope, next year could bring effective developments.
By injecting the cells, which have the ability to turn into any cell of the body, they hope to replace damaged neurons.
Members of the four Nervous System Repair teams from Europe and the U.S. met to share progress being made in the Society funded Promise: 2010 initiative. The first clinical trials focused on protecting the nervous system will begin shortly, and trials aimed at repairing damage and restoring function in people with MS are expected to begin within the next five years.
Users browsing this forum: Jimpsull